Funding and Investments

Oct 12, 2017
By BioPharm International Editors
NIH has entered a five-year, $215-million collaboration with leading biopharmaceutical companies to advance the development of cancer immunotherapies.
Jul 19, 2017
By BioPharm International Editors
GSK plans to invest in several UK manufacturing sites and to close its Slough site in conjunction with the sale of the Horlicks brand manufactured in Slough.
Jun 27, 2017
By BioPharm International Editors
BIO report measures decade-long investment and acquisition trends for emerging biotech companies.
Jun 22, 2017
By BioPharm International Editors
A loan from the European Investment Bank will give BiondVax resources for Phase III trials and a manufacturing facility for its universal flu vaccine.
May 01, 2017
By BioPharm International Editors
GSK invests $139 million to expand production capacity for Benlysta (belimumab) in Rockville, MD.
Dec 16, 2016
By BioPharm International Editors
Univercells received a grant from the Bill & Melinda Gates Foundation for the development of a vaccine manufacturing platform.
Dec 15, 2016
By BioPharm International Editors
DuPont received a grant from the Bill & Melinda Gates Foundation to produce pharmaceutical proteins.
Dec 15, 2016
By BioPharm International Editors
Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.
Dec 14, 2016
By BioPharm International Editors
BMS changes its US geographic footprint with R&D investments and closures.
Nov 16, 2016
By BioPharm International Editors
Despite some progress, pharmaceutical companies have a long way to go in making their products accessible and affordable, this year's study finds.
native1_300x100
lorem ipsum